Strongbridge Biopharma

-$0.01 (-0.44%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell SBBP and other stocks, options, and ETFs commission-free!

About SBBP

Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide.

CEO
John H. Johnson
Employees
72
Headquarters
Trevose, Pennsylvania
Founded
2015

SBBP Key Statistics

Market Cap
150.07M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
436.13K
High Today
$2.34
Low Today
$2.26
Open Price
$2.30
Volume
254.76K
52 Week High
$4.63
52 Week Low
$1.87

SBBP News

BenzingaMay 12

Looking Into Strongbridge Biopharma's Return On Capital Employed

During Q1, Strongbridge Biopharma (NASDAQ:SBBP) brought in sales totaling $8.38 million. However, earnings decreased 3.15%, resulting in a loss of $10.07 millio
BenzingaMay 12

Recap: Strongbridge Biopharma Q1 Earnings

Shares of Strongbridge Biopharma (NASDAQ:SBBP) fell 3.7% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share ros

SBBP Earnings

-$0.27
-$0.21
-$0.16
-$0.10
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.10 per share
Actual
-$0.11 per share
Replay Earnings Call

You May Also Like

LRCX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure